Angewandte
Chemie
kinetic data, to calculate the ee values from Equation (5) or (6). The
measured ee values were plotted against the actual values.
dehydrogenases for analysis of the ee value of a given alcohol.
3) The analysis method is very sensitive. The technique can be
used to determine the ee value of a sample with a concen-
tration as low as 200 mm and is therefore particularly useful for
biocatalyst screening, where product concentration is often
low. 4) The analysis is performed with UV spectroscopy; no
special instrument is required. 5) Experiments are performed
in a 96-well microtiter plate, which allows analysis of the
ee values of 48 samples within 5 min. Given a preparation
time of 5 min, about 288 samples can be analyzed in an hour,
which is a high enough throughput for most practical
applications. 6) The method can be extended to measure the
ee values of other types of compounds. Two enzymes of
another type may be applied, coupled with detection by UV
spectroscopy, MS, or even HPLC or GC for short analysis
times. 7) The method also provides the possibility to measure
concentration. For high concentrations, samples may be
diluted and then analyzed, which makes the method useful
for screening catalyst activities.
Received: October 10, 2003
Revised: January 8, 2004[Z53055]
Keywords: alcohols · asymmetric catalysis · dehydrogenation ·
.
enantioselectivity · high-throughput screening
[1] a) Chiralityin Industr:y The Commercial Manufacture and
Applications of OpticallyActive Compounds
(Eds.: A. N.
Collins, G. N. Sheldrake, J. Crosby), Wiley, Chichester, 1992;
b) Chiralityin IndustryII: Developments in the Commercial
Manufacture and Applications of OpticallyActive Compounds
(Eds.: A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, Chi-
chester, 1997; c) Chiralityin Agrochemicals (Eds.: N. Kurihara, J.
Miyamoto), Wiley, Chichester, 1998; d) Chiralityin Liquid
Crystals (Ed.: H.-S. Kitzerow), Springer, New York, 2001.
[2] For a review, see: a) A. Berkessel, Curr. Opin. Chem. Biol. 2003,
7, 409 – 419; b) J. P. Stambuli, J. F. Hartwig, Curr. Opin. Chem.
Biol. 2003, 7, 420 – 426; c) A. Hagemeyer, B. Jandeleit, Y. Liu,
D. M. Poojary, H. W. Turner, A. F. Volpe, Jr., W. H. Weinberg,
Appl. Catal. A 2001, 221, 23 – 43; d) K. W. Kuntz, M. L. Snapper,
A. H. Hoveyda, Curr. Opin. Chem. Biol. 1999, 3, 313 – 319.
[3] For a review, see: a) M. T. Reetz, K.-E. Jaeger, Chem. Eur. J.
2000, 6, 407 – 412; b) K.-E. Jaeger, M. T. Reetz, Curr. Opin.
Chem. Biol. 2000, 4, 68 – 73; c) M. T. Reetz, Tetrahedron 2002,
58, 6595 – 6602.
Further investigations will focus on the application of this
method to the discovery of enantioselective biological and/or
chemical catalysts. The scope and possible limitations of the
method will also be explored.
[4] For examples, see: a) M. T. Reetz, A. Zonta, K. Schimossek, K.
Liebeton, K.-E. Jaeger, Angew. Chem. 1997, 109, 2961 – 2963;
Angew. Chem. Int. Ed. Engl. 1997, 36, 2830 – 2832; b) M. T.
Reetz, S. Wilensek, D. Zha, K.-E. Jaeger, Angew. Chem. 2001,
113, 3701 – 3703; Angew. Chem. Int. Ed. 2001, 40, 3589 – 3591;
c) D. Zha, S. Wilensek, M. Hermes, K.-E. Jaeger, M. T. Reetz,
Chem. Commun. 2001, 2664– 2665; d) E. Henke, T. Bornscheu-
er, Biol. Chem. 1999, 380, 1029 – 1033; e) O. May, P. T. Nguyen,
F. H. Arnold, Nat. Biotechnol. 2000, 18, 317 – 320.
[5] a) E. T. Farinas, T. Bulter, F. H. Arnold, Curr. Opin. Biotechnol.
2001, 12, 545 – 551; b) W. P. C. Stemmer, Proc. Natl. Acad. Sci.
USA 1994, 91, 10747 – 10751; c) W. P. C. Stemmer, Nature 1994,
370, 389 – 391.
[6] For a review, see: a) M. T. Reetz, Angew. Chem. 2001, 113, 292 –
320; Angew. Chem. Int. Ed. 2001, 40, 284– 310; b) M. T. Reetz,
Angew. Chem. 2002, 114, 1391 – 1394; Angew. Chem. Int. Ed.
2002, 41, 1335 – 1338; c) D. Wahler, J.-L. Reymond, Curr. Opin.
Biotechnol. 2001, 12, 535 – 544; d) J. F. Traverse, M. L. Snapper,
Drug DiscoveryToday 2002, 7, 1002 – 1012; e) M. G. Finn,
Chirality 2002, 14, 534– 540.
[7] a) M. T. Reetz, A. Zonta, K. Schimossek, K. Liebeton, K.-E.
Jaeger, Angew. Chem. 1997, 109, 2961 – 2963; Angew. Chem. Int.
Ed. Engl. 1997, 36, 2830 – 2832; b) M. T. Reetz, M. H. Becker,
K. M. Kuehling, A. Holzwarth, Angew. Chem. 1998, 110, 2792 –
2795; Angew. Chem. Int. Ed. 1998, 37, 2647 – 2649; c) L. E. Janes,
R. J. Kazlauskas, J. Org. Chem. 1997, 62, 4560 – 4561; d) G. Klein,
J.-L. Reymond, Helv. Chim. Acta 1999, 82, 400 – 407; e) F.
Badalassi, D. Wahler, G. Klein, P. Crotti, J.-L. Reymond, Angew.
Chem. 2000, 112, 4233 – 4236; Angew. Chem. Int. Ed. 2000, 39,
4067 – 4070.
Experimental Section
Enzymes: LKADH was obtained from Fluka as a lyophilized powder
with an activity of 0.4Umg ꢀ1 for the reduction of acetophenone.
TBADH was purchased from Aldrich as a lyophilized powder with an
activity of 4.7 Umgꢀ1 for the oxidation of 2-propanol. READH was
obtained from Juelich Fine Chemicals as a solution with an activity of
144 UmLꢀ1 for the reduction of p-chloroacetophenone. The enzyme
stock solutions were freshly prepared each day, kept in aqueous
buffer at 48C, and used for measurement of the kinetic data and for
the analysis of the ee value.
General procedure for measurement of the ee value: A mixture
of buffer, alcohol 4, NAD(P)+, and enzyme with a total volume of
200 mL was pipetted into individual deep wells in a microtiter plate
and the absorption of the produced NAD(P)H at 340 nm was
measured for 5 minutes at 25 or 408C on a Spectra Max Plus
photometer with an optical density resolution of 0.001. Data points
were recorded every 12 s, which gave 26 points for every measure-
ment. The absorption data were used to calculate the NAD(P)H
concentration from a previously established standard curve. The
initial reaction velocity was calculated by linear regression as the
slope of a plot of [NAD(P)H] versus time.
The kinetic constants were quickly obtained by oxidizing (R)-4,
(S)-4, and mixtures of the enantiomers at various concentrations by
treatment with a single enzyme on a microtiter plate. The average
velocities calculated from three measurements and the alcohol
concentrations were used as input for the program Enzfit, which
was used to calculate the values of Km and Vmax. To determine the
inhibition constant KI, Lineweaver–Burk (L-B) plots of vꢀ1 versus
[S]ꢀ1 were generated for various inhibitor concentrations. A graph of
the slopes of the L–B plots versus the inhibitor concentration was
created. The value of KI was determined by dividing the intercept by
the slope of this plot.
[8] a) M. T. Reetz, K. M. Kꢀhling, S. Wilensek, H. Husmann, U. W.
Hꢁusig, M, Hermes, Catal. Today 2001, 67, 389 – 396; b) K.
Ding, A. Ishii, K. Mikami, Angew. Chem. 1999, 111, 519 – 523;
Angew. Chem. Int. Ed. 1999, 38, 497 – 501; c) K. Mikami, R.
Angelaud, K. Ding, A. Ishii, A. Tanaka, N. Sawada, K. Kudo, M.
Senda, Chem. Eur. J. 2001, 7, 730 – 737; d) M. T. Reetz, K. M.
Kuehling, A. Deege, H. Hinrichs, D. Belder, Angew. Chem. 2000,
112, 4049 – 4052; Angew. Chem. Int. Ed. 2000, 39, 3891 – 3893;
To measure the ee value, samples containing the two enantiomers
in various ratios and at a range of concentrations were prepared in
microtiter plates and separately oxidized with each of two enzymes.
The oxidation velocities were measured and used, together with
Angew. Chem. Int. Ed. 2004, 43, 1698 –1702
ꢀ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1701